Alafair Biosciences, Inc.

Alafair Biosciences, Inc. is a privately held, commercial-stage medical device company founded in 2011, with a focus on improving patient outcomes through the prevention of unwanted soft tissue tethering in all surgical applications. The company's patented hydrogel technology forms the basis of its novel clinical products, supported by a robust patent portfolio covering a broad range of clinical applications. Alafair is dedicated to building a strong product pipeline based on its proprietary technology, and its products are distributed through an extensive network of independent distributors across the United States. The latest milestone for Alafair Biosciences is its $7.20M Series B investment on 20 April 2019. The company remains focused on its mission within the Biotechnology and Health Care industries, attracting interest and support from potential investors. With a clear vision and innovative technology, Alafair Biosciences presents a compelling opportunity for investors looking to make an impact in the medical device sector.